Video

DDNA19: Cardiac Complications in Liver Disease Patients


 

AT DIGESTIVE DISEASES: NEW ADVANCES

Vidyard Video

Dr. Marc Klapholz of Rutgers University, Newark, N.J., explains the latest developments in portopulmonary arterial hypertension, hepatopulmonary syndrome, and cirrhotic cardiomyopathy, as well as the emerging field and association between non-alcoholic fatty liver disease and cardiovascular disease.

Recommended Reading

Skin rashes often accompany drug-induced liver injury
MDedge Family Medicine
Early treatment with direct-acting antivirals linked to reduced medical costs in noncirrhotic HCV
MDedge Family Medicine
Daily hydroxyurea effective, safe for African children
MDedge Family Medicine
AVERT: Apixaban reduced thromboembolism risk in cancer patients
MDedge Family Medicine
It’s time for universal HCV screening in the ED
MDedge Family Medicine
Biomarker algorithm may offer noninvasive look at liver fibrosis
MDedge Family Medicine
Risk-based testing missed 35% of HCV-positive prison inmates
MDedge Family Medicine
Perceptions of liver transplantation for ALD are evolving
MDedge Family Medicine
Women survive more often than men do when hospitalized with cirrhosis
MDedge Family Medicine
One-time, universal hepatitis C testing cost effective, researchers say
MDedge Family Medicine